View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis.
Authors: Deodhar, Atul1 (AUTHOR) deodhara@ohsu.edu, Nowak, Miroslawa2 (AUTHOR), Ye, June Y.3 (AUTHOR), Lehman, Tom4 (AUTHOR), Banerjee, Subhashis5 (AUTHOR), Mease, Philip J.6 (AUTHOR)
Source: Rheumatology & Therapy. Oct2025, Vol. 12 Issue 5, p873-887. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 188124947
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Deodhar%2C+Atul%22">Deodhar, Atul</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> deodhara@ohsu.edu</i><br /><searchLink fieldCode="AR" term="%22Nowak%2C+Miroslawa%22">Nowak, Miroslawa</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ye%2C+June+Y%2E%22">Ye, June Y.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lehman%2C+Tom%22">Lehman, Tom</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Banerjee%2C+Subhashis%22">Banerjee, Subhashis</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mease%2C+Philip+J%2E%22">Mease, Philip J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Rheumatology+%26+Therapy%22">Rheumatology & Therapy</searchLink>. Oct2025, Vol. 12 Issue 5, p873-887. 15p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188124947
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40744-025-00776-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 873
    Titles:
      – TitleFull: Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Deodhar, Atul
      – PersonEntity:
          Name:
            NameFull: Nowak, Miroslawa
      – PersonEntity:
          Name:
            NameFull: Ye, June Y.
      – PersonEntity:
          Name:
            NameFull: Lehman, Tom
      – PersonEntity:
          Name:
            NameFull: Banerjee, Subhashis
      – PersonEntity:
          Name:
            NameFull: Mease, Philip J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 21986576
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Rheumatology & Therapy
              Type: main
ResultId 1